USPTO serial 78854728
SALVIATHYMOL
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- BUONGIORNO, CHRISTOPHER L
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SALVIATHYMOL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alan B. Clement
ALAN B CLEMENT HEDMAN & COSTIGAN PC1185 AVENUE OF THE AMERICASNEW YORK, NY 10036-2601UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | cosmetics; cosmetic preparations for the care of mouth, teeth and gums; hygiene products, namely, oral cleansing sprays for cleaning for oral cavity, pharyngeal cavity, tongue, teeth and dentures, not for medical purposes; hygiene products, namely, breath fresheners not for medical purposes, breath freshening sprays not for medical purposes, breath freshening drops not for medical purposes, breath freshening tablets not for medical purposes, tooth polishes, tooth powders, tooth ointments, tooth gels and tooth gels for the prevention of and protective treatment for dental caries and prophylaxis; hygiene products, namely, dental bleaching gels, dental bleaching chewing gums, denture polishes, denture cleaners and denture cleaning preparations; natural essential oils; non-medicated mouth washes and mouth rinses, dentifrices | ABANDONED | — |
| 005 | pharmaceutical preparations for use in the treatment, cure, mitigation and/or prevention of gingivitis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity, inflammation of the pharyngeal cavity, sore mouth, sore gums, sore throat, injury of the mouth and gums, periodontal diseases, dental caries, hypersensitivity of teeth; pharmaceutical preparations for sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older, pain due to gingivitis, stomatitis, periodontitis, hypersensitivity of teeth and other diseases and conditions of the mouth, gums, oral cavity and pharyngeal cavity; veterinary preparations for use in the treatment, cure, mitigation and/or prevention of gingivitis halitosis, stomatitis, periodontitis, inflammation of the oral cavity, inflammation of the pharyngeal cavity, sore mouth, sore gums, sore throat, injury of the mouth and gums, periodontal diseases, dental caries, hypersensitivity of teeth; plant extracts for veterinary and pharmaceutical purposes; pharmaceutical products, namely, medicated dental gums and mouth washes, medicated mouth rinses, plaque disclosing reagents, periodontal diagnostic reagents for detecting derivatives from periodontal bacteria, caries diagnostic reagents for detecting derivatives from caries-causal bacteria; pharmaceutical products, namely, medicines for the prevention and treatment of periodontal diseases, dental caries, canker sores, cold sores, mucositis and oral and tongue cancers; pharmaceutical products, namely, medicated toothpastes, medicated oral-care gels, medicated dental gels, lozenges in the nature of throat lozenges, medicated lozenges, cough lozenges, medicated chewing gum; pharmaceutical products, namely, medicated gels and fluid in the nature of dental bleaching gels, gums, balms; pharmaceutical products, namely, medicated chewing gums and lozenges which provide a protective dental and gingival barrier, coating and sealant for preventive, prophylactic and therapeutic hygiene use; pharmaceutical products, namely, medicated dental floss, medicated dental tapes, medicated dental ribbons; medicated teeth whitening gels, medicated toothpicks, fluoride chewing gum, chewable tablets for disclosing dental plaque and tartar; pharmaceutical products, namely, antiseptics, oral antiseptic, disinfectants for hygienic purposes; pharmaceutical products, namely, mouth sprays which provide a protective dental gingival barrier, coating and sealant for preventive, prophylactic, therapeutic hygiene use and dentin desensitizers; pharmaceutical products, namely, medicated dentifrices; dietary supplements; food supplements and dietary food supplements | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2009 | MAB5 | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | — |
| Oct 8, 2009 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Oct 7, 2009 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Aug 17, 2009 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Aug 17, 2009 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 17, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 18, 2009 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 18, 2009 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 18, 2009 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 23, 2008 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 23, 2008 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 23, 2008 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 19, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 27, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 7, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 19, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 18, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 18, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 18, 2007 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 18, 2007 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 18, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 27, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Sep 27, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 21, 2007 | PAPER RECEIVED | — | |
| Mar 21, 2007 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 21, 2007 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 28, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Feb 28, 2007 | ALIE | ASSIGNED TO LIE | — |
| Jan 31, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 31, 2007 | PAPER RECEIVED | — | |
| Aug 1, 2006 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 1, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 1, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 11, 2006 | NWAP | NEW APPLICATION ENTERED | — |